MedTrace Logo

AVANDAMET Versus Metformin And Sulphonylurea In People With Poorly Controlled Type 2 Diabetes

NCT00359112 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 544

Last updated 2009-05-18

No results posted yet for this study

Summary

This study compares the effects of Avandamet (rosiglitazone maleate/metformin) treatment and metformin plus sulphonylurea treatment in overweight people with type 2 diabetes.

Conditions

  • Non-Insulin-Dependent Diabetes Mellitus

Interventions

DRUG

metformin

DRUG

sulphonylurea

DRUG

Avandamet

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials, DM, FRCP · GlaxoSmithKline

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-02-29

Countries

  • Belgium
  • France
  • Germany
  • Ireland
  • Italy
  • Lithuania
  • Mexico
  • Netherlands
  • Spain
  • Switzerland
  • United Kingdom

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00359112 on ClinicalTrials.gov